Progen Matériel de laboratoire

Description

CDX-2 is a caudal-related homeobox transcription factor that plays a role in the development and maintenance of intestinal mucosa. It is expressed early in intestinal development and is involved in the regulation of intestinal epithelial cell proliferation and differentiation, localized to the villi and crypt surfaces of the intestinal epithelium. CDX2 deficiency promotes the development of sporadic colon cancers, and is also a distinguishing feature of large-cell, poorly-differentiated colon cancers. This protein is expressed in normal and neoplastic gastrointestinal epithelium, including colorectal adenocarcinoma. It is useful for identifying gastrointestinal origin of benign and malignant lesions.1-7 — Références — 1. Mazziotta, Robert M et al. "CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall." Applied immunohistochemistry & molecular morphology : AIMM vol. 13,1 (2005): 55-60. 2. Erickson, Lori A et al. "Cdx2 as a marker for neuroendocrine tumors of unknown primary sites." Endocrine pathology vol. 15,3 (2004): 247-52. 3. Saqi, Anjali et al. "Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids." American journal of clinical pathology vol. 123,3 (2005): 394-404. 4. Saad, Reda S et al. "Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma." American journal of clinical pathology vol. 122,3 (2004): 421-7. 5. Kaimaktchiev, Vassil et al. "The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 17,11 (2004): 1392-9. 6. Werling, Robert W et al. "CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas." The American journal of surgical pathology vol. 27,3 (2003): 303-10. 7. Moskaluk, Christopher A et al. "Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 16,9 (2003): 913-9.

Caractéristiques

Type
Recombinant monoclonal rabbit antibody
Clone
DA035
Isotype
Rabbit
Réactivité
Synthetic peptide of human CDX-2
Localisation
Nucleus
Usage prévu
IHC (FFPE)

Conditionnements disponibles

2 référence(s) catalogue.

N° catalogue Type Dilution Volume
RMA1A062 Concentrate 1:100 – 1:300 0.1ml, 0.5ml, 1ml Demander un devis →
RMA1A062 Ready to use 1:100 – 1:300 3ml, 6ml, 10ml Demander un devis →

Intéressé par ce produit ?

Indiquez la référence et le conditionnement souhaités, nous revenons vers vous rapidement.

Demander un devis